Syndax Pharmaceuticals, Inc. (SNDX)
19.48
-0.03
(-0.15%)
USD |
NASDAQ |
Dec 10, 13:59
Syndax Pharmaceuticals Profit Margin (Quarterly): -132.4% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | 7.47% |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Verastem, Inc. | -876.3% |
| Puma Biotechnology, Inc. | 16.24% |
| Krystal Biotech, Inc. | 81.15% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -136.4% |
| Return on Assets | -53.00% |
| Return on Invested Capital | -61.68% |
| Gross Profit Margin (Quarterly) | 95.42% |
| Operating Margin (Quarterly) | -125.2% |
| Return on Net Operating Assets | -868.8% |